599 related articles for article (PubMed ID: 27002798)
1. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.
Loomba R; Cui J; Wolfson T; Haufe W; Hooker J; Szeverenyi N; Ang B; Bhatt A; Wang K; Aryafar H; Behling C; Valasek MA; Lin GY; Gamst A; Brenner DA; Yin M; Glaser KJ; Ehman RL; Sirlin CB
Am J Gastroenterol; 2016 Jul; 111(7):986-94. PubMed ID: 27002798
[TBL] [Abstract][Full Text] [Related]
2. Editorial: Magnetic Resonance Elastography and Non-Alcoholic Fatty Liver Disease: Time for an Upgrade?
Flores A; Asrani SK
Am J Gastroenterol; 2016 Jul; 111(7):995-6. PubMed ID: 27356823
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
Cui J; Heba E; Hernandez C; Haufe W; Hooker J; Andre MP; Valasek MA; Aryafar H; Sirlin CB; Loomba R
Hepatology; 2016 Feb; 63(2):453-61. PubMed ID: 26560734
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Furlan A; Tublin ME; Yu L; Chopra KB; Lippello A; Behari J
AJR Am J Roentgenol; 2020 Jan; 214(1):W20-W26. PubMed ID: 31714842
[No Abstract] [Full Text] [Related]
5. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.
Cui J; Ang B; Haufe W; Hernandez C; Verna EC; Sirlin CB; Loomba R
Aliment Pharmacol Ther; 2015 Jun; 41(12):1271-80. PubMed ID: 25873207
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.
Loomba R; Wolfson T; Ang B; Hooker J; Behling C; Peterson M; Valasek M; Lin G; Brenner D; Gamst A; Ehman R; Sirlin C
Hepatology; 2014 Dec; 60(6):1920-8. PubMed ID: 25103310
[TBL] [Abstract][Full Text] [Related]
7. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G
Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172
[TBL] [Abstract][Full Text] [Related]
8. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
Zhang YN; Fowler KJ; Boehringer AS; Montes V; Schlein AN; Covarrubias Y; Wolfson T; Hong CW; Valasek MA; Andre MP; Loomba R; Sirlin CB
Eur Radiol; 2022 Apr; 32(4):2457-2469. PubMed ID: 34854929
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
[TBL] [Abstract][Full Text] [Related]
10. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
[TBL] [Abstract][Full Text] [Related]
13. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study.
Shi Y; Xia F; Li QJ; Li JH; Yu B; Li Y; An H; Glaser KJ; Tao S; Ehman RL; Guo QY
Am J Gastroenterol; 2016 Jun; 111(6):823-33. PubMed ID: 26977760
[TBL] [Abstract][Full Text] [Related]
15. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Jung J; Loomba RR; Imajo K; Madamba E; Gandhi S; Bettencourt R; Singh S; Hernandez C; Valasek MA; Behling C; Richards L; Fowler K; Sirlin CB; Nakajima A; Loomba R
Gut; 2021 Oct; 70(10):1946-1953. PubMed ID: 33214165
[TBL] [Abstract][Full Text] [Related]
16. Performance of 2-Dimensional Ultrasound Shear Wave Elastography in Liver Fibrosis Detection Using Magnetic Resonance Elastography as the Reference Standard: A Pilot Study.
Song P; Mellema DC; Sheedy SP; Meixner DD; Karshen RM; Urban MW; Manduca A; Sanchez W; Callstrom MR; Greenleaf JF; Chen S
J Ultrasound Med; 2016 Feb; 35(2):401-12. PubMed ID: 26782164
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Tamaki N; Imajo K; Sharpton S; Jung J; Kawamura N; Yoneda M; Valasek MA; Behling C; Sirlin CB; Nakajima A; Loomba R
Hepatology; 2022 Mar; 75(3):661-672. PubMed ID: 34496054
[TBL] [Abstract][Full Text] [Related]
18. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy.
Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Rezvani R; Ghaffarzadegan K; Nooghabi MJ; Shalchian P; Zangui M; Javid Z; Doaei S; Rajabzadeh F
Obes Surg; 2019 Aug; 29(8):2585-2592. PubMed ID: 31077025
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.
Schwimmer JB; Behling C; Angeles JE; Paiz M; Durelle J; Africa J; Newton KP; Brunt EM; Lavine JE; Abrams SH; Masand P; Krishnamurthy R; Wong K; Ehman RL; Yin M; Glaser KJ; Dzyubak B; Wolfson T; Gamst AC; Hooker J; Haufe W; Schlein A; Hamilton G; Middleton MS; Sirlin CB
Hepatology; 2017 Nov; 66(5):1474-1485. PubMed ID: 28493388
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
Ajmera VH; Liu A; Singh S; Yachoa G; Ramey M; Bhargava M; Zamani A; Lopez S; Mangla N; Bettencourt R; Rizo E; Valasek M; Behling C; Richards L; Sirlin C; Loomba R
Hepatology; 2020 Mar; 71(3):849-860. PubMed ID: 31556124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]